CompletedNCT00663000

Glucose Tolerance in Acromegaly: The Influence of GH-excess on Glucose Metabolism and Insulin Resistance

Studying Acromegaly

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital Tuebingen
Principal Investigator
Baptist Gallwitz, MD, Prof.
Dept. Medicine IV. Tuebingen University
Enrollment
138 enrolled
Eligibility
18-75 years · All sexes
Timeline
20082012

Study locations (6)

Collaborators

Pfizer · Ludwig-Maximilians - University of Munich

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00663000 on ClinicalTrials.gov

Other trials for Acromegaly

Additional recruiting or active studies for the same condition.

See all trials for Acromegaly

← Back to all trials